Stem cell treatments for amyotrophic lateral sclerosis: A critical overview of early phase trials (vol 28, pg 525, 2019)

被引：0
|
作者：
Goutman, S. A.
Savelieff, M. G.
Sakowski, S. A.
机构：
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2019年 / 29卷 / 07期
关键词：
D O I：
10.1080/13543776.2019.1639316
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：579 / 585
页数：7
相关论文
共 50 条
  • [1] Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials
    Goutman, Stephen A.
    Savelieff, Masha G.
    Sakowski, Stacey A.
    Feldman, Eva L.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (06) : 525 - 543
  • [2] Stem Cell. Therapy for Amyotrophic Lateral Sclerosis - an Overview of Current Clinical Experience
    Baumgartner, D.
    Marusic, P.
    Mazanec, R.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2017, 80 (01) : 27 - 33
  • [3] Amyotrophic lateral sclerosis: Current and future treatment strategies (vol 51, pg 28, 1996)
    Festoff, BW
    DRUGS, 1996, 52 (01) : 92 - 92
  • [4] Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials?
    Atassi, Nazem
    Beghi, Ettore
    Blanquer, Miguel
    Boulis, Nicholas M.
    Cantello, Roberto
    Caponnetto, Claudia
    Chio, Adriano
    Dunnett, Stephen B.
    Feldman, Eva L.
    Vescovi, Angelo
    Mazzini, Letizia
    CYTOTHERAPY, 2016, 18 (12) : 1471 - 1475
  • [5] New molecular diagnostic trends and biomarkers for amyotrophic lateral sclerosis (vol 40, pg 361, 2019)
    Pampalakis, Georgios
    Mitropoulos, Konstantinos
    Xiromerisiou, Georgia
    Dardiotis, Efthymios
    Deretzi, Georgia
    Anagnostouli, Maria
    Katsila, Theodora
    Rentzos, Michail
    Patrinos, George P.
    HUMAN MUTATION, 2019, 40 (11) : 2265 - 2265
  • [6] Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial
    Mazzini, L.
    Ferrero, I.
    Luparello, V.
    Rustichelli, D.
    Gunetti, M.
    Mareschi, K.
    Testa, L.
    Stecco, A.
    Tarletti, R.
    Miglioretti, M.
    Fava, E.
    Nasuelli, N.
    Cisari, C.
    Massara, M.
    Vercelli, R.
    Oggioni, G. D.
    Carriero, A.
    Cantello, R.
    Monaco, F.
    Fagioli, F.
    EXPERIMENTAL NEUROLOGY, 2010, 223 (01) : 229 - 237
  • [7] A novel muscle cramp scale (MCS) in amyotrophic lateral sclerosis (ALS) (vol 22, pg 1, 2019)
    Mitsumoto, H.
    Chiuzan, C.
    Gilmore, M.
    Zhang, Y.
    Ibagon, C.
    Mchale, B.
    Hupf, J.
    Oskarsson, B.
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2019, 20 (5-6) : 457 - 457
  • [8] Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: Phase 1 trial outcomes
    Feldman, Eva L.
    Boulis, Nicholas M.
    Hur, Junguk
    Johe, Karl
    Rutkove, Seward B.
    Federici, Thais
    Polak, Meraida
    Bordeau, Jane
    Sakowski, Stacey A.
    Glass, Jonathan D.
    ANNALS OF NEUROLOGY, 2014, 75 (03) : 363 - 373
  • [9] Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials (vol 89, pg 1915, 2017)
    van Eijk, R. P. A.
    Jones, A. R.
    Sproviero, W.
    NEUROLOGY, 2017, 89 (22) : 2303 - 2303
  • [10] The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins (vol 68, pg 407, 2019)
    Deora
    GLIA, 2020, 68 (10) : 2167 - 2168
12345